GTCbio is proud to present the Protease Inhibitors in Drug Discovery Conference to be held on February 26-27, 2015 in San Diego, CA!

We are pleased to announce the inaugural Protease Inhibitors in Drug Discovery Conference, to be hosted by GTCbio February 26-27, 2015 in San Diego, CA. Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity.

This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, deubiquitinating enzymes, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.

Sessions for the meeting include:
I. Targeting Proteases in the Cardiovascular System
II. Protease Inibitors in Infection and Immunity
III. Protease Inhibitors in Cancer Therapy
IV. Membrane-Associated Systems
V. Deubiquitinating Enzymes Inhibitors
VI. Non-Active Site Inhibition of Proteases
VII. Advances in Protease Targeted Therapies

Please review: https://www.gtcbio.com/conferences/protease-inhibitors-drug-discovery-overview?utm_source=pidd&utm_medium=EventListing&utm_campaign=pidd